See more : CASI Pharmaceuticals, Inc. (CASI) Income Statement Analysis – Financial Results
Complete financial analysis of CBTX, Inc. (CBTX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CBTX, Inc., a leading company in the Banks – Regional industry within the Financial Services sector.
- Enel Américas S.A. (ENELAM.SN) Income Statement Analysis – Financial Results
- CT UK High Income Ord (CHI.L) Income Statement Analysis – Financial Results
- Telecom Plus Plc (TEP.L) Income Statement Analysis – Financial Results
- B & A Limited (BNALTD.BO) Income Statement Analysis – Financial Results
- Tata Technologies Limited (TATATECH.NS) Income Statement Analysis – Financial Results
CBTX, Inc. (CBTX)
About CBTX, Inc.
CBTX, Inc. operates as the bank holding company for CommunityBank of Texas, National Association that provides commercial banking products and services to small and mid-sized businesses, and professionals in the United States. The company offers demand, money market, savings, and time deposit accounts, as well as certificates of deposit; commercial and industrial, commercial real estate, construction and development, 1-4 family residential mortgage, multi-family residential, consumer, and agricultural loans; and treasury and online banking services. It operates through 34 banking locations, including 18 branches in Houston; 15 branches in Beaumont; and one branch in Dallas. The company was formerly known as CBFH, Inc. and changed its name to CBTX, Inc. in September 2017. CBTX, Inc. was incorporated in 2007 and is headquartered in Beaumont, Texas.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|---|---|---|
Revenue | 590.82M | 322.99M | 142.43M | 143.39M | 154.35M | 138.65M | 121.69M | 116.98M | 111.49M |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 590.82M | 322.99M | 142.43M | 143.39M | 154.35M | 138.65M | 121.69M | 116.98M | 111.49M |
Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 7.96M | 3.58M | 79.01M | 64.33M | 64.87M | 60.52M | 56.17M | 52.00M | 49.18M |
Selling & Marketing | 3.63M | 2.46M | 1.55M | 1.50M | 1.83M | 1.82M | 1.46M | 789.40K | 925.00K |
SG&A | 11.58M | 6.04M | 80.57M | 65.83M | 66.70M | 62.35M | 57.64M | 52.79M | 50.11M |
Other Expenses | 0.00 | 0.00 | -171.55M | -166.74M | -141.56M | -131.24M | -126.42M | -122.15M | -119.01M |
Operating Expenses | 11.58M | 6.04M | -90.99M | -100.91M | -74.85M | -68.90M | -68.78M | -69.35M | -68.91M |
Cost & Expenses | 11.58M | 6.04M | -90.99M | -100.91M | -74.85M | -68.90M | -68.78M | -69.35M | -68.91M |
Interest Income | 24.56M | 20.35M | 132.09M | 138.69M | 153.40M | 135.76M | 116.66M | 109.95M | 105.53M |
Interest Expense | 154.06M | 34.04M | 5.93M | 10.09M | 17.41M | 11.10M | 8.89M | 8.40M | 7.65M |
Depreciation & Amortization | 41.05M | 19.98M | 4.94M | 5.60M | 5.44M | 4.29M | 4.43M | 4.43M | 4.95M |
EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 52.05M | 47.53M |
EBITDA Ratio | 27.40% | 29.90% | 39.59% | 33.53% | 55.03% | 53.41% | 47.12% | 44.50% | 42.63% |
Operating Income | 161.88M | 96.56M | 51.44M | 42.48M | 79.50M | 69.75M | 52.91M | 47.62M | 42.58M |
Operating Income Ratio | 27.40% | 29.90% | 36.12% | 29.63% | 51.50% | 50.31% | 43.48% | 40.71% | 38.19% |
Total Other Income/Expenses | -417.35M | -254.43M | -5.93M | -10.09M | -17.41M | -11.10M | -8.89M | -8.40M | -7.65M |
Income Before Tax | 161.88M | 62.52M | 45.52M | 32.40M | 62.09M | 58.65M | 44.02M | 39.22M | 34.93M |
Income Before Tax Ratio | 27.40% | 19.36% | 31.96% | 22.59% | 40.23% | 42.30% | 36.18% | 33.53% | 31.33% |
Income Tax Expense | 31.39M | 11.09M | 9.92M | 6.03M | 11.57M | 11.36M | 16.45M | 12.01M | 10.79M |
Net Income | 130.50M | 51.43M | 35.60M | 26.36M | 50.52M | 47.29M | 27.57M | 27.21M | 24.14M |
Net Income Ratio | 22.09% | 15.92% | 24.99% | 18.38% | 32.73% | 34.11% | 22.66% | 23.26% | 21.65% |
EPS | 5.33 | 1.48 | 1.45 | 1.06 | 2.02 | 1.89 | 1.23 | 1.11 | 1.11 |
EPS Diluted | 5.33 | 1.47 | 1.45 | 1.06 | 2.02 | 1.89 | 1.22 | 1.11 | 1.08 |
Weighted Avg Shares Out | 24.46M | 0.00 | 24.54M | 24.80M | 25.05M | 25.02M | 22.46M | 24.46M | 21.84M |
Weighted Avg Shares Out (Dil) | 24.46M | 0.00 | 24.54M | 24.80M | 25.05M | 25.02M | 22.57M | 24.46M | 22.33M |
Chicago Equity Partners LLC Has $701,000 Position in CBTX Inc (NASDAQ:CBTX)
Analyzing Limestone Bancorp (NASDAQ:LMST) & CBTX (NASDAQ:CBTX)
CBTX (NASDAQ:CBTX) Hits New 12-Month Low at $25.85
Analysts Expect CBTX Inc (NASDAQ:CBTX) to Announce $0.47 Earnings Per Share
South Africa beat England by six wickets: Women's T20 World Cup – as it happened
Comparing CBTX (NASDAQ:CBTX) & Centerstate Bank (NASDAQ:CSFL)
CBTX Enters Oversold Territory
If You Had Bought CBTX (NASDAQ:CBTX) Stock A Year Ago, You'd Be Sitting On A 10% Loss, Today
CBTX (NASDAQ:CBTX) Stock Rating Upgraded by TheStreet
Zacks: Brokerages Set $31.00 Price Target for CBTX Inc (NASDAQ:CBTX)
Source: https://incomestatements.info
Category: Stock Reports